Literature DB >> 26278999

A study of MRI changes in Wilson disease and its correlation with clinical features and outcome.

A Ranjan1, J Kalita2, S Kumar3, S K Bhoi1, U K Misra1.   

Abstract

OBJECTIVE: To evaluate the sensitivity of different MRI sequences in Wilson disease (WD) with neurological manifestations and its correlation with clinical features and outcome.
METHODS: 34 WD patients with neurological manifestation with a median age of 14 years were included. Their Mini Mental State Examination (MMSE) score, movement disorders and laboratory findings were noted. Cranial MRI in T1, T2, FLAIR and DW sequences were done. Outcome at 6 months was categorized into improved (>1 grade improvement), static or worsening.
RESULTS: MRI was abnormal in all and revealed involvement of putamen in 29 (85.3%), caudate in 23 (67.6%), brainstem and globus pallidus in 21 (61.8%) each, thalamus in 20 (58.8%), cerebral cortex in 9 (26.5%), subcortical white matter in 8 (23.5%), and cerebellum in 2 (5.9%) patients. The overall sensitivity of T2 and FLAIR was 97.1% each, DWI 38.2% and T1 31.4%. None had contrast enhancement and 4 had reduced ADC value. Choreoathetosis correlated with thalamic, pallidal and putaminal lesions; MMSE with subcortical white mater. MRI load correlated with age, tremor, psychiatric disorder, choreoathetosis, and severity of WD. At 6 months 9 (26.5%) patients improved, 18 (52.9%) remained static and 6 (17.6%) deteriorated.
CONCLUSION: In neurologic WD, putaminal involvement is the commonest; T2 and FLAIR sequences have similar sensitivity and number of MRI lesions correlated with disease severity but not with outcome.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  ADC; Athetosis; Chorea; Cognitive impairment; DRI; FLAIR; MRI; Movement disorder; Wilson disease; Worsening

Mesh:

Year:  2015        PMID: 26278999     DOI: 10.1016/j.clineuro.2015.07.013

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  11 in total

Review 1.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

2.  Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury.

Authors:  Jayantee Kalita; Vijay Kumar; Usha K Misra; Sunil Kumar
Journal:  J Mol Neurosci       Date:  2020-07-13       Impact factor: 3.444

3.  Memory and Learning Dysfunction Following Copper Toxicity: Biochemical and Immunohistochemical Basis.

Authors:  Jayantee Kalita; Vijay Kumar; Usha K Misra; Himangsu K Bora
Journal:  Mol Neurobiol       Date:  2017-05-23       Impact factor: 5.590

4.  Pontomesencephalic Atrophy and Postural Instability in Wilson Disease.

Authors:  J Kalita; S Naik; S K Bhoi; U K Misra; A Ranjan; S Kumar
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-11       Impact factor: 3.825

5.  MR Imaging of the Brain in Neurologic Wilson Disease.

Authors:  X-E Yu; S Gao; R-M Yang; Y-Z Han
Journal:  AJNR Am J Neuroradiol       Date:  2019-01       Impact factor: 3.825

6.  Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity.

Authors:  Jayantee Kalita; Vijay Kumar; Vasudev Parashar; Usha K Misra
Journal:  Mol Neurobiol       Date:  2021-08-26       Impact factor: 5.590

7.  Wilson's Disease Update: An Indian Perspective.

Authors:  Niraj Kumar; L K Prashant; Vinay Goyal
Journal:  Ann Indian Acad Neurol       Date:  2021-10-14       Impact factor: 1.383

8.  Wilson's Disease Update: An Indian Perspective.

Authors:  Kalyan Bhattacharya; Bindu Thankappan
Journal:  Ann Indian Acad Neurol       Date:  2022-02-18       Impact factor: 1.383

Review 9.  Magnetic resonance imaging findings in diagnosis and prognosis of Wilson disease.

Authors:  Mehri Salari; Emad Fayyazi; Omid Mirmosayyeb
Journal:  J Res Med Sci       Date:  2018-03-27       Impact factor: 1.852

Review 10.  Bilateral lesions of the basal ganglia and thalami (central grey matter)-pictorial review.

Authors:  Sofie Van Cauter; Mariasavina Severino; Rosamaria Ammendola; Brecht Van Berkel; Hrvoje Vavro; Luc van den Hauwe; Zoran Rumboldt
Journal:  Neuroradiology       Date:  2020-08-05       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.